Hfciem Ferric Carboxymaltose injection 50mg

Get a Price/Quote

MOQ : 10 Pieces

Hfciem Ferric Carboxymaltose injection 50mg Specification

Indication
Iron deficiency anemia, especially in patients who cannot use oral iron or have not responded to it

Dosage Form
Injection

Salt Composition
Ferric Carboxymaltose 50mg

Feature
High-dose intravenous iron, rapid iron repletion, reduced frequency of administration

Ingredients
Ferric Carboxymaltose

Application
Parenteral administration for iron supplementation

Physical Color/Texture
Solution for injection (typically brown, clear solution)

Storage Instructions
Store below 25C. Protect from light. Do not freeze.

Shelf Life
24 months from manufacturing date

Pack Size
Each vial contains 50 mg/mL iron as ferric carboxymaltose, volume as per pack label

Prescription/OTC Status
Prescription only

Country Approvals
Approved and/or available in countries such as Canada, EU, UK, USA, Australia (per image flag representation)

Packaging Type
Glass vial

Contraindications
Known hypersensitivity to ferric carboxymaltose, iron overload, anemia not caused by iron deficiency

Marketed By
Abbott

Route of Administration
Intravenous (IV) infusion or injection

Common Adverse Effects
Nausea, dizziness, hypertension, injection site reactions

Maximum Single Dose
Usually 1000 mg iron (per clinical guidelines)

Brand Name
Hfciem

Hfciem Ferric Carboxymaltose injection 50mg About

Experience a hot deal on Hfciem Ferric Carboxymaltose injection 50mg-an impeccable solution by Abbott for iron deficiency anemia. Known for its dazzling efficacy, Hfciem is valorous in rapidly addressing iron needs in those unable to use oral iron. A cost-effective option, each glass vial contains high-dose ferric carboxymaltose (50mg/mL), providing swift iron repletion through IV infusion or injection. Approved worldwide, including in the USA, UK, EU, Canada, and Australia. Get it now on prescription for powerful, reliable anemia management!

Hfciem Ferric Carboxymaltose 50mg: Area of Application and Special Features

Hfciem Ferric Carboxymaltose injection 50mg, designed for parenteral administration, is primarily used in treating iron deficiency anemia in patients intolerant or unresponsive to oral iron. Its special features include high-dose intravenous delivery, fast iron repletion, and fewer required administrations for maximum efficacy. Used as an iron supplement, Hfciem guarantees reliable results with a valorous safety profile, perfect for hospitals and clinics demanding rapid, effective anemia management.

Export Market, Purchase Orders & Packaging Details for Hfciem Ferric Carboxymaltose 50mg

Hfciem Ferric Carboxymaltose injection enjoys robust demand in both domestic markets and leading export markets such as the USA, EU, UK, Canada, and Australia. Samples are typically available on request, supporting evaluation prior to final purchase order commitments. Packaging details include pharmaceutical-grade glass vials, clearly labeled with product specifics for seamless shipping. The manufacturer's efficient supply chain supports consistent global availability and tailored export documentation as required.

FAQ's of Hfciem Ferric Carboxymaltose injection 50mg:

Q: How is Hfciem Ferric Carboxymaltose injection administered?

A: Hfciem Ferric Carboxymaltose injection is given via intravenous (IV) infusion or injection by a healthcare professional, ensuring safe and accurate dosing for effective iron supplementation.

Q: What are the primary benefits of using Hfciem Ferric Carboxymaltose for anemia?

A: Hfciem Ferric Carboxymaltose offers rapid and high-dose iron repletion with reduced frequency of administration, making it ideal for patients with significant iron needs or who cannot tolerate oral iron.

Q: When should Hfciem Ferric Carboxymaltose be used instead of oral iron therapy?

A: Hfciem is recommended for patients who have not responded to or cannot use oral iron supplements, including those with severe intolerance, malabsorption, or requiring quick iron replenishment.

Q: Where can Hfciem Ferric Carboxymaltose injection be purchased or exported?

A: Hfciem is available in domestic markets across India and is also approved or supplied in countries including the EU, USA, UK, Canada, and Australia through authorized channels or upon purchase order.

Q: What precautions should be considered before using Hfciem Ferric Carboxymaltose?

A: Healthcare providers must screen for contraindications such as iron overload, hypersensitivity to ferric carboxymaltose, and non-iron deficiency anemia. Always use under medical supervision.

Q: What are common adverse effects associated with Hfciem Ferric Carboxymaltose?

A: Common side effects include nausea, dizziness, increased blood pressure, and reactions at the injection site. Patients should consult their healthcare provider if they experience any unusual symptoms.

Tell us about your requirement